Correction: Defining the Transcriptional and Cellular Landscape of Type 1 Diabetes in the NOD Mouse

Correction: Defining the Transcriptional and Cellular Landscape of Type 1 Diabetes in the NOD Mouse

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890366/?tool=EBI

Similar Items

Correction: Defining the Transcriptional and Cellular Landscape of Type 1 Diabetes in the NOD Mouse.
by: Javier A. Carrero, et al.
Published: (2014-01-01)

Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse.
by: Javier A Carrero, et al.
Published: (2013-01-01)

The NOD Mouse Beyond Autoimmune Diabetes
by: Anne-Marie Aubin, et al.
Published: (2022-04-01)

Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model
by: Elin Malek Abrahimians, et al.
Published: (2016-03-01)

Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse.
by: Xin Wang, et al.
Published: (2012-01-01)

Reversal of Hyperglycemia and Suppression of Type 1 Diabetes in the NOD Mouse with Apoptotic DNA Immunotherapy™ (ADi™), ADi-100
by: David G. Alleva, et al.
Published: (2020-03-01)

Defining the Progression of Diabetic Cardiomyopathy in a Mouse Model of Type 1 Diabetes
by: Miles J. De Blasio, et al.
Published: (2020-02-01)

CD226 Deletion Reduces Type 1 Diabetes in the NOD Mouse by Impairing Thymocyte Development and Peripheral T Cell Activation
by: Melanie R. Shapiro, et al.
Published: (2020-09-01)

Author Correction: Novel mode of defective neural tube closure in the non-obese diabetic (NOD) mouse strain
by: J. Michael Salbaum, et al.
Published: (2022-03-01)

REGULATION OF THE TRANSCRIPTIONAL AND CELLULAR LANDSCAPE OF THE ADULT MOUSE SUBVENTRICULAR ZONE BY THYROID HORMONE SIGNALING
by: Víctor Valcárcel Hernández, et al.
Published: (2023-10-01)

Dietary emulsifier consumption accelerates type 1 diabetes development in NOD mice
by: Clara Delaroque, et al.
Published: (2024-01-01)

Sustained high glucose intake accelerates type 1 diabetes in NOD mice
by: Xiangqian Li, et al.
Published: (2022-12-01)

Distinct Characteristics and Features of Allogeneic Chimerism in the NOD Mouse Model of Autoimmune Diabetes
by: Tatiana D. Zorina M.D., Ph.D., et al.
Published: (2002-03-01)

NSC23766, a Known Inhibitor of Tiam1-Rac1 Signaling Module, Prevents the Onset of Type 1 Diabetes in the NOD Mouse Model
by: Rajakrishnan Veluthakal, et al.
Published: (2016-07-01)

The type 1 diabetes susceptibility locus Idd5 favours robust neonatal development of highly autoreactive regulatory T cells in the NOD mouse
by: Jérémy C. Santamaria, et al.
Published: (2024-02-01)

Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?
by: David P. Funda, et al.
Published: (2019-05-01)

Defining mechanisms of NOD2 receptor function in myeloid cells
by: Chapman, TPE
Published: (2017)

Prevention or early cure of type 1 diabetes by intranasal administration of gliadin in NOD mice.
by: David P Funda, et al.
Published: (2014-01-01)

The tyrphostin agent AG490 prevents and reverses type 1 diabetes in NOD mice.
by: Abdoreza Davoodi-Semiromi, et al.
Published: (2012-01-01)

Comparative genomic analysis of buffalo (Bubalus bubalis) NOD1 and NOD2 receptors and their functional role in in-vitro cellular immune response.
by: Biswajit Brahma, et al.
Published: (2015-01-01)

Defining the transcriptional landscapes of human developing and aged tendons: insights into the signalling pathways and cellular contributions to regenerative tendon formation
by: Kurjan, A
Published: (2024)

Defining the dynamic chromatin landscape of mouse nephron progenitors
by: Sylvia Hilliard, et al.
Published: (2019-05-01)

NOD1 and NOD2 signaling in infection and inflammation
by: Lilian eMoreira, et al.
Published: (2012-11-01)

Defining the Transcriptional and Post-transcriptional Landscapes of Mycobacterium smegmatis in Aerobic Growth and Hypoxia
by: M. Carla Martini, et al.
Published: (2019-03-01)

Circulating platelet-neutrophil aggregates characterize the development of type 1 diabetes in humans and NOD mice
by: Sarah K. Popp, et al.
Published: (2022-01-01)

The Role of NOD Mice in Type 1 Diabetes Research: Lessons from the Past and Recommendations for the Future
by: Yi-Guang Chen, et al.
Published: (2018-02-01)

Exposure to bisphenol A, but not phthalates, increases spontaneous diabetes type 1 development in NOD mice
by: Johanna Bodin, et al.
Published: (2015-01-01)

The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions.
by: Cecile King, et al.
Published: (2011-02-01)

Axenic Caenorhabditis elegans antigen protects against development of type-1 diabetes in NOD mice
by: Belinda M. Jackson-Thompson, et al.
Published: (2020-01-01)

Adaptive Immunity and Pathogenesis of Diabetes: Insights Provided by the α4–Integrin Deficient NOD Mouse
by: Salim Oulghazi, et al.
Published: (2020-12-01)

Mediators of Metabolism: An Unconventional Role for NOD1 and NOD2
by: Megan T. Zangara, et al.
Published: (2021-01-01)

Glibenclamide Prevents Diabetes in NOD Mice.
by: Smaragda Lamprianou, et al.
Published: (2016-01-01)

Tolerance to Proinsulin-1 Reduces Autoimmune Diabetes in NOD Mice
by: Gaurang Jhala, et al.
Published: (2021-03-01)

Activation of NOD1 and NOD2 in the development of liver injury and cancer
by: Naoya Omaru, et al.
Published: (2022-10-01)

Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
by: Joanna Kern, et al.
Published: (2014-01-01)

Transcription of NOD1 and NOD2 and their interaction with CARD9 and RIPK2 in IFN signaling in a perciform fish, the Chinese perch, Siniperca chuatsi
by: Xue Yun Peng, et al.
Published: (2024-04-01)

GABA<sub>B</sub>-Receptor Agonist-Based Immunotherapy for Type 1 Diabetes in NOD Mice
by: Jide Tian, et al.
Published: (2021-01-01)

Bioluminescence imaging reveals dynamics of beta cell loss in the non-obese diabetic (NOD) mouse model.
by: John Virostko, et al.
Published: (2013-01-01)

Immunological Basis for Rapid Progression of Diabetes in Older NOD Mouse Recipients Post BM-HSC Transplantation.
by: Nan Wang, et al.
Published: (2015-01-01)

NOD-Like Receptors: Guards of Cellular Homeostasis Perturbation during Infection
by: Gang Pei, et al.
Published: (2021-06-01)